Sectors & Industries HealthcareHealth Information Services
Best Health Information Service Stocks to Buy Now (2025)
Top health information service stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best health information service stocks to buy now. Learn More.

Industry: Health Information Servic...

Overview Zen Rating Price Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Health Information Services is Zen Rated A and is the 20th ranked industry out of 145 stock market industries

Ticker	Company	DD Score	Valuation Score	Financials Score	Forecast Score	Performance Score	Dividends Score
TBRG	TRUBRIDGE INC	14	29	43	0	0	0
SPOK	SPOK HOLDINGS INC	43	43	71	11	30	60
OMCL	OMNICELL INC	33	14	71	44	0	–
BTSG	BRIGHTSPRING HEALTH SERVICES INC	29	14	29	44	30	–
VEEV	VEEVA SYSTEMS INC	51	0	100	44	60	–

Upgrade to Premium to View More

Use Due Diligence Score to quickly analyze stock fundamentals, even if you don't have a finance background. We run time-tested due diligence checks inspired by legendary investors like Warren Buffett, and score each company based on how many they pass/fail.

Already have a premium account?

Health Information Service Stocks FAQ

What are the best health information service stocks to buy right now in Jul 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best health information service stocks to buy right now are:

1. Trubridge (NASDAQ:TBRG)

Trubridge (NASDAQ:TBRG) is the #1 top health information service stock out of 56 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Trubridge (NASDAQ:TBRG) is: Value: C, Growth: A, Momentum: C, Sentiment: C, Safety: C, Financials: B, and AI: C.

Trubridge (NASDAQ:TBRG) has a Due Diligence Score of 14, which is -12 points lower than the health information service industry average of 26. Although this number is below the industry average, our proven quant model rates TBRG as a "A".

TBRG passed 5 out of 38 due diligence checks and has weak fundamentals. Trubridge has seen its stock return 129.37% over the past year, overperforming other health information service stocks by 194 percentage points.

Trubridge has an average 1 year price target of $28.50, an upside of 24.13% from Trubridge's current stock price of $22.96.

Trubridge stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Trubridge, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) is the #2 top health information service stock out of 56 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Spok Holdings (NASDAQ:SPOK) is: Value: C, Growth: C, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: B.

Spok Holdings (NASDAQ:SPOK) has a Due Diligence Score of 43, which is 17 points higher than the health information service industry average of 26.

SPOK passed 15 out of 38 due diligence checks and has strong fundamentals. Spok Holdings has seen its stock return 18.14% over the past year, overperforming other health information service stocks by 82 percentage points.

3. Omnicell (NASDAQ:OMCL)

Omnicell (NASDAQ:OMCL) is the #3 top health information service stock out of 56 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Omnicell (NASDAQ:OMCL) is: Value: B, Growth: A, Momentum: D, Sentiment: A, Safety: C, Financials: C, and AI: C.

Omnicell (NASDAQ:OMCL) has a Due Diligence Score of 33, which is 7 points higher than the health information service industry average of 26.

OMCL passed 10 out of 33 due diligence checks and has average fundamentals. Omnicell has seen its stock return 16.24% over the past year, overperforming other health information service stocks by 80 percentage points.

Omnicell has an average 1 year price target of $36.75, an upside of 23.45% from Omnicell's current stock price of $29.77.

Omnicell stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Omnicell, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the health information service stocks with highest dividends?

Out of 6 health information service stocks that have issued dividends in the past year, the 3 health information service stocks with the highest dividend yields are:

1. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 6.98%, which is 5 percentage points higher than the health information service industry average of 2.1%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 160.3% indicates that its high dividend yield might not be sustainable for the long-term.

2. Premier (NASDAQ:PINC)

Premier (NASDAQ:PINC) has an annual dividend yield of 3.91%, which is 2 percentage points higher than the health information service industry average of 2.1%. Premier's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Premier's dividend has shown consistent growth over the last 10 years.

Premier's dividend payout ratio of 150% indicates that its high dividend yield might not be sustainable for the long-term.

3. National Research (NASDAQ:NRC)

National Research (NASDAQ:NRC) has an annual dividend yield of 2.21%, which is the same as the health information service industry average of 2.1%. National Research's dividend payout is not stable, having dropped more than 10% four times in the last 10 years. National Research's dividend has not shown consistent growth over the last 10 years.

National Research's dividend payout ratio of 46.2% indicates that its dividend yield is sustainable for the long-term.

Why are health information service stocks down?

Health information service stocks were down -0.97% in the last day, and down -1.47% over the last week.

We couldn't find a catalyst for why health information service stocks are down.

What are the most undervalued health information service stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued health information service stocks right now are:

1. Goodrx Holdings (NASDAQ:GDRX)

Goodrx Holdings (NASDAQ:GDRX) is the most undervalued health information service stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Goodrx Holdings has a valuation score of 29, which is 12 points higher than the health information service industry average of 17. It passed 2 out of 7 valuation due diligence checks.

Goodrx Holdings's stock has dropped -38.67% in the past year. It has overperformed other stocks in the health information service industry by 26 percentage points.

2. Solventum (NYSE:SOLV)

Solventum (NYSE:SOLV) is the second most undervalued health information service stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Solventum has a valuation score of 29, which is 12 points higher than the health information service industry average of 17. It passed 2 out of 7 valuation due diligence checks.

Solventum's stock has gained 57.49% in the past year. It has overperformed other stocks in the health information service industry by 122 percentage points.

3. Nutex Health (NASDAQ:NUTX)

Nutex Health (NASDAQ:NUTX) is the third most undervalued health information service stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Nutex Health has a valuation score of 71, which is 54 points higher than the health information service industry average of 17. It passed 5 out of 7 valuation due diligence checks.

Nutex Health's stock has gained 2,609.91% in the past year. It has overperformed other stocks in the health information service industry by 2,674 percentage points.

Are health information service stocks a good buy now?

54.05% of health information service stocks rated by analysts are a strong buy right now. On average, analysts expect health information service stocks to rise by 23% over the next year.

9.76% of health information service stocks have a Zen Rating of A (Strong Buy), 29.27% of health information service stocks are rated B (Buy), 53.66% are rated C (Hold), 2.44% are rated D (Sell), and 4.88% are rated F (Strong Sell).

What is the average p/e ratio of the health information services industry?

The average P/E ratio of the health information services industry is 42.54x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.